Preoperative lymphocyte count, neutrophil to lymphocyte and platelet to lymphocyte ratio predict the recurrence with progression and cancerization in vocal fold lesions-retrospective study.

Blood markers Laryngeal cancer Laryngeal dysplasia Lymphocyte count Neutrophil count Neutrophil to lymphocyte ratio

Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2023
Historique:
received: 21 02 2023
accepted: 05 06 2023
medline: 26 9 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

This study explored the contribution of peripheral blood markers in diagnosis and prognosis estimation of different stages of laryngeal dysplasia and early glottic cancer. Retrospective analysis of clinical, histopathological and laboratory data of 220 patients including hemoglobin, neutrophil, lymphocyte, monocyte and platelet counts, neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR). The mean hemoglobin level and platelets count showed differences between histopathological stages of lesions ( The levels of blood cells and their ratios seem to be effective in predicting the recurrence of lesion and even more their potential role in indicating malignant progression.

Sections du résumé

Backgrounds
This study explored the contribution of peripheral blood markers in diagnosis and prognosis estimation of different stages of laryngeal dysplasia and early glottic cancer.
Methods
Retrospective analysis of clinical, histopathological and laboratory data of 220 patients including hemoglobin, neutrophil, lymphocyte, monocyte and platelet counts, neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR).
Results
The mean hemoglobin level and platelets count showed differences between histopathological stages of lesions (
Conclusions
The levels of blood cells and their ratios seem to be effective in predicting the recurrence of lesion and even more their potential role in indicating malignant progression.

Identifiants

pubmed: 37744219
doi: 10.7717/peerj.15642
pii: 15642
pmc: PMC10517654
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15642

Informations de copyright

©2023 Rzepakowska et al.

Déclaration de conflit d'intérêts

The authors declare there are no competing interests.

Références

Asian Pac J Cancer Prev. 2014;15(17):7351-5
pubmed: 25227841
Laryngoscope. 2002 Mar;112(3):488-93
pubmed: 12148859
PLoS One. 2014 Jun 06;9(6):e98259
pubmed: 24906014
Eur J Surg Oncol. 2018 May;44(5):607-612
pubmed: 29478743
Surgery. 2015 Jul;158(1):112-20
pubmed: 25818659
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Front Immunol. 2019 Jul 18;10:1690
pubmed: 31379875
Dis Markers. 2020 Aug 01;2020:7241785
pubmed: 32831972
Surg Oncol. 2020 Dec;35:374-381
pubmed: 33035785
Head Neck. 2014 Jul;36(7):947-53
pubmed: 23733351
Sci Rep. 2016 Feb 25;6:22089
pubmed: 26912340
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
PLoS One. 2014 Mar 25;9(3):e93102
pubmed: 24667986
Ann Surg Oncol. 2016 Feb;23(2):646-54
pubmed: 26416715
BMC Cancer. 2018 Aug 13;18(1):816
pubmed: 30103707
Med Sci Monit. 2019 Jun 18;25:4527-4534
pubmed: 31210172
Asian Pac J Cancer Prev. 2014;15(6):2647-50
pubmed: 24761878
Ann Surg Oncol. 2015 Jul;22(7):2343-50
pubmed: 25472648
Acta Otolaryngol. 2019 Mar;139(3):294-298
pubmed: 30882257
Acta Otolaryngol. 1990 Sep-Oct;110(3-4):309-13
pubmed: 2239223
Cancer Res. 2011 Apr 1;71(7):2411-6
pubmed: 21427354
Eur Arch Otorhinolaryngol. 2019 Oct;276(10):2857-2864
pubmed: 31367834
Head Neck Pathol. 2017 Mar;11(1):23-32
pubmed: 28247231
Br J Cancer. 2014 May 13;110(10):2524-30
pubmed: 24675383
Head Neck. 2019 May;41(5):1525-1535
pubmed: 30597654
Nat Rev Dis Primers. 2020 Nov 26;6(1):92
pubmed: 33243986
J Cell Physiol. 2014 Aug;229(8):1005-15
pubmed: 24374897
Eur Urol Oncol. 2018 Oct;1(5):403-410
pubmed: 31158079
Radiother Oncol. 2016 Feb;118(2):330-4
pubmed: 26653356
BMC Cancer. 2014 Feb 21;14:117
pubmed: 24559042
Head Neck. 2018 May;40(5):1091-1100
pubmed: 29356179
Oncology. 2000 Feb;58(2):117-25
pubmed: 10705238
Curr Opin Otolaryngol Head Neck Surg. 2016 Apr;24(2):121-7
pubmed: 26963671
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4863-4869
pubmed: 34357460
Nat Rev Cancer. 2016 Jul;16(7):431-46
pubmed: 27282249
Niger J Clin Pract. 2019 May;22(5):701-706
pubmed: 31089026

Auteurs

Anna Rzepakowska (A)

Department of Otorhinolaryngology Head and Neck Surgery, Medical University of Warsaw, Warsaw, Poland.

Wioletta Pietruszewska (W)

Department of Otiatrics, Laryngology and Laryngological Oncology, Medical University of Łódź, Łódź, Poland.

Michał Żurek (M)

Department of Otorhinolaryngology Head and Neck Surgery, Medical University of Warsaw, Warsaw, Poland.
Doctoral School, Medical University of Warsaw, Warsaw, Poland.

Maria Molga-Magusiak (M)

Department of Otorhinolaryngology Head and Neck Surgery, Medical University of Warsaw, Warsaw, Poland.

Michał Leszczyński (M)

Department of Otorhinolaryngology Head and Neck Surgery, Medical University of Warsaw, Warsaw, Poland.

Kazimierz Niemczyk (K)

Department of Otorhinolaryngology Head and Neck Surgery, Medical University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH